Projects
- Project 1: Critical Path Project: Mapp66, a Multi-antibody Prevention Product
- A. Mapp Pharmaceutical
- PI: Kevin J. Whaley, PhD
- Co-PI: Larry Zeitlin, PhD
- Co-I: Michael Pauly, PhD
- B. Kentucky BioProcessing
- C. Aridis Pharmaceutical
- Project 2: MAbs in the Cervicovaginal Environment: Cellular Interactions and Host Defense
- PI: Deborah J. Anderson, PhD
- Co-I: Joseph A. Politch, PhD
- Co-I: Jeffrey Pudney, PhD
- Project 3: Optimizing Plantibodies for Trapping HIV and HSV in Cervicovaginal Mucus
- A. University of North Carolina at Chapel Hill
- B. Johns Hopkins University
- Project 4: Vaginal mAb Delivery Systems
- A. ReProtect
- B. Auritec
- Co-PI: Thomas Smith, PhD
- Co-I: Amanda M. Malone, PhD
- Project 5: Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates
- PI: Francois Villinger, DVM, PhD
- Co-PI: Prachi Sharma, DVM, PhD
- Project 6: A Pharmacokinetic and Pharmacodynamic Study of an Antibody-Based Vaginal Microbicide
-
A. Fenway Health
- B. The Miriam Hospital
- Co-PI: Susan Cu-Uvin, MD
- Co-I: Kathleen Morrow, PhD